For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230913:nRSM3502Ma&default-theme=true
RNS Number : 3502M Glantus Holdings PLC 13 September 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION
FOR IMMEDIATE RELEASE
13 September 2023
RECOMMENDED CASH ACQUSITION
OF
GLANTUS HOLDINGS PLC
BY
GENESIS BIDCO LIMITED
(A NEWLY INCORPORATED PRIVATE LIMITED COMPANY WHOLLY-OWNED BY BASWARE OY)
TO BE IMPLEMENTED BY WAY OF A SCHEME OF ARRANGEMENT UNDER CHAPTER 1 OF PART 9
OF THE COMPANIES ACT 2014
Results of the Scheme Meeting and the Extraordinary General Meeting
On 14 August 2023, Genesis Bidco Limited ("Bidco") and the board of directors
of Glantus Holdings plc ("Glantus" or the "Company") announced that they had
reached agreement on the terms of a recommended all cash offer by Bidco, which
has been unanimously recommended by the Glantus Board and pursuant to which
Bidco, a newly incorporated private limited company wholly-owned by Basware Oy
("Basware"), will acquire the entire issued and to be issued share capital of
Glantus (the "Acquisition"). It is intended that the Acquisition will be
implemented by means of a High Court sanctioned scheme of arrangement under
Chapter 1 of Part 9 of the Act (the "Scheme").
Result of the Scheme Meeting and Extraordinary General Meeting
Glantus is pleased to announce that, at the Scheme Meeting and Extraordinary
General Meeting ("EGM") (together, the "Meetings") each held earlier today,
the requisite majority of Scheme Shareholders voted (either in person or by
proxy) to approve the Scheme at the Scheme Meeting and the requisite majority
of Glantus Shareholders (either in person or by proxy) voted to pass the EGM
Resolutions in connection with the implementation of the Scheme, including the
amendment to Glantus' articles of association, at the EGM.
The Resolutions were therefore duly passed. Full details of the Resolutions
are set out in the notice of the Scheme Meeting and the notice of the EGM of
Glantus contained in Parts IX and X of the Scheme Document, respectively.
The total number of Glantus Shares in issue at the Voting Record Time was
51,132,553. Glantus does not hold any ordinary shares in treasury. Therefore,
the total voting rights in Glantus at the Voting Record Time were 51,132,553.
Voting results of the Scheme Meeting
The Scheme Meeting sought approval from holders of Scheme Shares for the
Scheme. Each Scheme Shareholder, present in person or by proxy, was entitled
to vote one Scheme Share held at the Voting Record Time.
A majority in number of Scheme Shareholders who voted (either in person or by
proxy), representing 100 per cent. by value of those Scheme Shares voted in
favour of the Scheme Meeting Resolution to approve the Scheme.
Accordingly, the Scheme Meeting Resolution proposed at the Scheme Meeting was
duly passed.
Details of the votes cast were as follows:
No. of Scheme Shareholders present and voting in person or by proxy % of Scheme Shareholders present and voting in person or by proxy No. of Scheme Shares present and voting in person or by proxy % of Scheme Shares present and voting in person or by proxy % of Shares present and voting in person or by proxy as a % of all Scheme
Shares in issue
For 17 80.95 36,751,520 100.00 71.87
Against 0 0 0 0 0
Total 17 80.95 36,751,520 100.00 71.87
Abstain 1 3,139
Voting results of the Extraordinary General Meeting
The Extraordinary General Meeting sought approval for the resolutions for the
purpose of giving effect to the Scheme and associated amendments to the
articles of association of the Company.
Each Glantus Shareholder, present in person or by proxy, was entitled to one
vote per Glantus Share held at the Voting Record Time.
The EGM Resolutions was duly passed by the requisite majority.
Details of the votes cast were as follows:
Ordinary Resolution
No. of Glantus Shareholders present and voting in person or by proxy No. of Glantus Shares present and voting in person or by proxy % of Glantus Shares present and voting in person or by proxy
For 18 35,012,236 100
Against 0 0 0
Total 18 35,012,236 100
Abstain 1 588,235
Special Resolution
No. of Glantus Shareholders present and voting in person or by proxy No. of Glantus Shares present and voting in person or by proxy % of Glantus Shares present and voting in person or by proxy
For 17 35,010,717 100
Against 0 0 0
Total 17 35,010,717 100
Abstain 2 589,754
Irrevocable undertakings
In the Scheme Document it was reported that Bidco had received irrevocable
undertakings that represent approximately 72.34% of the issued share capital
of Glantus on 11 August 2023 (being the latest practicable date prior to the
publication of the Announcement). Unfortunately, due to circumstances beyond
the control of those Glantus Shareholders giving the irrevocable undertakings,
certain nominees through whom such Shareholders hold shares did not manage to
appoint proxies by the required deadlines. These counted for, in aggregate,
2,533,104 Scheme Shares in respect of the Scheme Meeting and 4,746,517 Glantus
Shares in respect of the EGM.
Next steps and timetable
The outcome of today's Meetings means that Conditions 2.1, 2.2 and 2.3 (as set
out in Part V of the Scheme Document) have been satisfied. The Scheme remains
subject to the satisfaction or (where applicable) waiver of the remaining
Conditions as set out in Part III of the Scheme Document, including (amongst
other things) the sanction of the Scheme by the Court at the Court Hearing and
the delivery of a copy of the Court Order to the Registrar of Companies.
The expected timetable of principal events for the implementation of the
Scheme remains as set out on page 6 of the Scheme Document and as set out in
the appendix below. The dates are indicative only and are subject to change.
The dates will depend, among other things, on the dates upon which: (i) the
Conditions are satisfied or (if capable of waiver) waived; (ii) the Court
sanctions the Scheme; and (iii) a copy of the Court Order is delivered to the
Registrar of Companies.
If any of the expected times and/or dates change, the revised times and/or
dates will be notified by Glantus through a Regulatory Information
Service. Any revisions or changes to these dates and/or times will be
notified in the same way.
Capitalised terms used and not defined in this announcement have the meanings
given to them in the Scheme Document.
All references to times are to times in London unless otherwise stated.
Enquiries
Glantus Holdings
Maurice Healy, CEO + 353 862677800
Susan O'Connor, Interim CFO
Shore Capital (Financial Adviser, Nominated Adviser and Broker to Glantus) + 44 207 408 4090
Patrick Castle
Tom Knibbs
Lucy Bowden
Yellow Jersey PR (Public Relations Advisor to Glantus) +44 7747 788 221
Charles Goodwin
Annabelle Wills
Basware + 358 09 879171
Jason Kurtz, CEO
Martti Nurminen, CFO
Rothschild & Co (Financial Advisor to Basware and Bidco) +44 20 7280 5000
Anton Black
Mitul Manji
Tom Guinness
Statements required by the Irish Takeover Rules
The Bidco Directors and the Basware Directors accept responsibility for the
information contained in this Announcement other than that relating to
Glantus, the Glantus Group and the Glantus Directors and members of their
immediate families, related trusts and persons connected with them. To the
best of the knowledge and belief of the Bidco Directors and the Basware
Directors (who, in each case, have taken all reasonable care to ensure that
this is the case), the information contained in this Announcement for which
they accept responsibility is in accordance with the facts and does not omit
anything likely to affect the import of such information.
The Glantus Directors accept responsibility for the information contained in
this Announcement relating to Glantus, the Glantus Group and the Glantus
Directors and members of their immediate families, related trusts and persons
connected with them. To the best of the knowledge and belief of the Glantus
Directors (who, in each case, have taken all reasonable care to ensure such is
the case), the information contained in this Announcement for which they
accept responsibility is in accordance with the facts and does not omit
anything likely to affect the import of such information.
Shore Capital, which is authorised and regulated by the FCA in the United
Kingdom, is acting exclusively for Glantus and no one else in connection with
the Acquisition and other matters referred to in this Announcement and will
not be responsible to anyone other than Glantus for providing the protections
afforded to clients of Shore Capital, or for providing advice in connection
with the Acquisition, the content of this Announcement or any matter or
arrangement referred to herein. Neither Shore Capital nor any of its
subsidiaries or affiliates, directors, officers employees or agents owes or
accepts any duty, liability or responsibility whatsoever (whether direct,
indirect, consequential, whether in contract, in tort, under statute or
otherwise) to any person who is not a client of Shore Capital in connection
with this Announcement, the Acquisition, any statement contained herein or
otherwise.
N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is
authorised and regulated by the FCA in the United Kingdom, is acting
exclusively for Bidco and Basware as financial adviser and no one else in
connection with the Acquisition and other matters set out in this Announcement
and will not be responsible to anyone other than Bidco and Basware for
providing the protections afforded to clients of Rothschild & Co, or for
providing advice in connection with the Acquisition, the content of this
Announcement or any matter or arrangement referred to herein. Neither
Rothschild & Co nor any of its affiliates or partners, directors, officers
employees or agents owes or accepts any duty, liability or responsibility
whatsoever (whether direct, indirect, consequential, whether in contract, in
tort, under statute or otherwise) to any person who is not a client of
Rothschild & Co in connection with this Announcement, the Acquisition, any
statement contained herein or otherwise.
Arthur Cox LLP is acting as legal adviser to Bidco and Basware and DAC
Beachcroft LLP is acting as legal adviser to Glantus.
No Offer or Solicitation
This Announcement is for information purposes only and is not intended to, and
does not, constitute or form any part of any offer or invitation, or the
solicitation of an offer, to purchase or otherwise acquire, subscribe for,
sell or otherwise dispose of any securities or the solicitation of any vote or
approval in any jurisdiction pursuant to the Acquisition or otherwise, nor
shall there be any sale, issuance or transfer of securities in any
jurisdiction in contravention of applicable law. The Acquisition will be made
solely by means of the Scheme Document (or, if applicable, the Takeover Offer
Document), which will contain the full terms and conditions of the
Acquisition, including details of how to vote in respect of the Acquisition.
Any decision in respect of, or other response to, the Acquisition, should be
made only on the basis of the information contained in the Scheme Document
(or, if applicable, the Takeover Offer Document).
This Announcement does not constitute a prospectus or a prospectus equivalent
document.
Cautionary Statement Regarding Forward-Looking Statements
This Announcement contains certain forward-looking statements with respect to
Bidco, Basware and Glantus. These forward-looking statements can be identified
by the fact that they do not relate only to historical or current facts.
Forward-looking statements often use words such as "anticipate", "target",
"expect", "estimate", "intend", "plan", "believe", "will", "may", "would",
"could" or "should" or other words of similar meaning or the negative thereof.
The expectations and beliefs of Bidco, Basware and Glantus regarding these
matters may not materialise. Actual outcomes and results may differ materially
from those contemplated by these forward looking statements as a result of
uncertainties, risks, and changes in circumstances, including but not limited
to risks and uncertainties related to: the ability of Glantus and Bidco to
consummate the Acquisition in a timely manner or at all; the satisfaction (or
waiver) of any conditions to the consummation of the Acquisition, including
with respect to the approval of Glantus Shareholders and any required
regulatory approvals; potential delays in consummating the Acquisition; the
ability of Glantus and Bidco to timely and successfully achieve the
anticipated strategic benefits or opportunities expected as a result of the
Acquisition; the successful integration of Glantus into the Basware Group
subsequent to Completion and the timing of such integration; the impact of
changes in global, political, economic, business, competitive, market and
regulatory forces; the occurrence of any event, change or other circumstance
or condition that could give rise to the termination of the Transaction
Agreement; adverse effects on the market price of Glantus' securities and on
the Glantus or the Basware Group's operating results because of a failure to
complete the Acquisition; and the effect of the announcement or pendency of
the Acquisition on the Glantus or Basware business relationships, operating
results and business generally; and the costs related to the Acquisition.
These forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of any such person, or industry results, to be
materially different from any results, performance or achievements expressed
or implied by such forward-looking statements. These forward-looking
statements are based on numerous assumptions regarding the present and future
business strategies of such persons and the environment in which each will
operate in the future. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. All
subsequent oral or written forward-looking statements attributable to Bidco,
Basware or Glantus or any persons acting on their behalf are expressly
qualified in their entirety by the cautionary statement above. Neither Bidco,
the Basware Group nor Glantus undertake any obligation to update publicly or
revise forward-looking or other statements contained in this Announcement,
whether as a result of new information, future events or otherwise, except to
the extent legally required.
Disclosure requirements of the Irish Takeover Rules
Under the provisions of Rule 8.3(a) of the Irish Takeover Rules, any person
who is 'interested' in 1% or more of any class of 'relevant securities' of the
Company must make an 'opening position disclosure' following the commencement
of the 'offer period'. An 'opening position disclosure' must contain the
details contained in Rule 8.6(a) of the Irish Takeover Rules, including, among
other things, details of the person's 'interests' and 'short positions' in any
'relevant securities' of the Company. An 'opening position disclosure' by a
person to whom Rule 8.3(a) applies must be made by no later than 3:30pm.
(GMT+1) on the day falling ten 'business days' following the commencement of
the 'offer period'. Relevant persons who deal in any 'relevant securities'
prior to the deadline for making an 'opening position disclosure' must instead
make a 'dealing' disclosure as described below.
Under the provisions of Rule 8.3(b) of the Irish Takeover Rules, if any person
is, or becomes, 'interested' in 1% or more of any class of 'relevant
securities' of the Company, that person must publicly disclose all 'dealings'
in any 'relevant securities' of the Company during the 'offer period', by not
later than 3:30pm. (GMT+1) on the 'business day' following the date of the
relevant transaction.
If two or more persons co-operate on the basis of any agreement either express
or tacit, either oral or written, to acquire an 'interest' in 'relevant
securities' of the Company or any securities exchange offeror, they will be
deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover
Rules.
In addition, any offeror must make an 'opening position disclosure' by no
later 12:00 noon (GMT+1) on the date falling ten 'business days' following the
commencement of the 'offer period' or the announcement that first identifies a
securities exchange offeror, as applicable, and disclose details of any
'dealings' by it or any person 'acting in concert' with it in 'relevant
securities' during the 'offer period', by no later than 12:00 noon (GMT+1) on
the business day following the date of the transaction (see Irish Takeover
Rules 8.1, 8.2 and 8.4).
A disclosure table, giving details of the companies in whose 'relevant
securities' 'dealings' should be disclosed, can be found on the Irish Takeover
Panel's website at www.irishtakeoverpanel.ie.
(https://url.avanan.click/v2/___http:/www.irishtakeoverpanel.ie/___.YXAxZTpzaG9yZWNhcDphOm86YWE2YzE4ZGM2ZDFhM2YwMjRkZDIxMTgzODA5ZGY1ZjQ6NjpkNzUxOjMwNzk4Mjg0MDE3YjBlNDIxYWMyMDBjNDAyOWMzZGQyNWU4YTYwZmRjMzc1ZDhhNmY0MTI2NmVmMzAwZjM2ZGU6cDpU)
'Interests in securities' arise, in summary, when a person has long economic
exposure, whether conditional or absolute, to changes in the price of
securities. In particular, a person will be treated as having an 'interest' by
virtue of the ownership or control of securities, or by virtue of any option
in respect of, or derivative referenced to, securities.
Terms in quotation marks are defined in the Irish Takeover Rules, which can
also be found on the Irish Takeover Panel's website. If you are in any doubt
as to whether or not you are required to disclose a dealing under Rule 8,
please consult the Irish Takeover Panel's website at www.irishtakeoverpanel.ie
(https://url.avanan.click/v2/___http:/www.irishtakeoverpanel.ie/___.YXAxZTpzaG9yZWNhcDphOm86YWE2YzE4ZGM2ZDFhM2YwMjRkZDIxMTgzODA5ZGY1ZjQ6NjpkNzUxOjMwNzk4Mjg0MDE3YjBlNDIxYWMyMDBjNDAyOWMzZGQyNWU4YTYwZmRjMzc1ZDhhNmY0MTI2NmVmMzAwZjM2ZGU6cDpU)
or contact the Irish Takeover Panel on telephone number +353 1 678 9020.
No profit forecast, estimate or asset valuations
No statement in this Announcement is intended as a profit forecast or estimate
for any period and no statement in this Announcement should be interpreted to
mean that earnings or earnings per share for Bidco, Basware or Glantus
respectively for the current or future financial years would necessarily match
or exceed the historical published earnings or earnings per share for Bidco,
Basware or Glantus respectively. No statement in this Announcement constitutes
an asset valuation.
Right to switch to a Takeover Offer
Bidco reserves the right to elect, subject to the terms of the Transaction
Agreement, compliance with the Irish Takeover Rules and with the consent of
the Irish Takeover Panel, to implement the Acquisition by way of a Takeover
Offer for the entire issued and to be issued share capital of Glantus as an
alternative to the Scheme. In such an event, the Takeover Offer will be
implemented on the same terms (subject to appropriate amendments), so far as
applicable, as those which would apply to the Scheme and subject to the
amendments referred to in Appendix I to this Announcement and in the
Transaction Agreement.
Publication on website
Pursuant to Rule 26.1 of the Irish Takeover Rules, this Announcement will be
made available on Basware's website (https://www.basware.com/
(https://url.avanan.click/v2/___https:/www.basware.com/___.YXAxZTpzaG9yZWNhcDphOm86YWE2YzE4ZGM2ZDFhM2YwMjRkZDIxMTgzODA5ZGY1ZjQ6NjplYTQwOmM3OGZkNjJiOGYzNTgzZjM1ZTQ2Y2QzMmZjMmYxOTViNDQ5ZGEyMTRiNTUzMGMzNGI1MTgxNzBiNTc4MzlmZjE6cDpU)
) and on Glantus' website (https://www.glantus.com/
(https://url.avanan.click/v2/___https:/www.basware.com/___.YXAxZTpzaG9yZWNhcDphOm86YWE2YzE4ZGM2ZDFhM2YwMjRkZDIxMTgzODA5ZGY1ZjQ6NjplYTQwOmM3OGZkNjJiOGYzNTgzZjM1ZTQ2Y2QzMmZjMmYxOTViNDQ5ZGEyMTRiNTUzMGMzNGI1MTgxNzBiNTc4MzlmZjE6cDpU)
) by no later than 12:00 noon (GMT+1) on the 'business day' following this
Announcement.
Neither the content of any such website nor the content of any other website
accessible from hyperlinks on such website is incorporated into, or forms part
of, this Announcement.
Rounding
Certain figures included in this Announcement have been subjected to rounding
adjustments. Accordingly, figures shown for the same category presented in
different tables may vary slightly and figures shown as totals in certain
tables may not be an arithmetic aggregation of the figures that precede them.
The aggregate amount payable to each Glantus Shareholder in accordance with
the Acquisition shall be rounded down to the nearest whole pence value.
Requesting hard copy documents
Any Glantus Shareholder may request a copy of this Announcement or the Scheme
Document in hard copy form by writing to Glantus (Attn: Paula Nolan, Company
Secretary, Glantus Holdings plc, Marina House, Block V, Eastpoint Business
Park, Dublin, D03 AX24, Ireland) or Bidco, (Attn: Genesis Bidco Limited, 10
Earlsfort Terrace, Dublin 2, D02 T380). Any written requests must include the
identity of the Glantus Shareholder and any hard copy documents will be posted
to the address of the Glantus Shareholder provided in the written request. If
you have received this Announcement and/or the Scheme Document in electronic
form, a hard copy of this Announcement and/or the Scheme Document will not be
provided unless such a request is made.
Electronic Communications
Please be aware that addresses, electronic addresses and certain other
information provided by Glantus Shareholders, persons with information rights
and other relevant persons for the receipt of communications from Glantus may
be provided to Bidco during the offer period as required under Section 4 of
Appendix 1 of the Irish Takeover Rules to comply with Rule 2.10(b).
General
The laws of certain jurisdictions may affect the availability of the
Acquisition to persons who are not resident in Ireland or the United Kingdom.
Persons who are not resident in Ireland or the United Kingdom, or who are
subject to laws of any jurisdiction other than Ireland or the United Kingdom,
should inform themselves about, and observe, any applicable legal or
regulatory requirements. Any failure to comply with any applicable legal or
regulatory requirements may constitute a violation of the laws and/or
regulations of any such jurisdiction. To the fullest extent permitted by
applicable law, the companies and persons involved in the Acquisition disclaim
any responsibility and liability for the violation of such restrictions by any
person.
This Announcement has been prepared for the purpose of complying with the Laws
of Ireland and the Irish Takeover Rules and the information disclosed may not
be the same as that which would have been disclosed if this Announcement had
been prepared in accordance with the Laws of jurisdictions outside of Ireland.
Unless otherwise determined by Basware and Bidco or required by the Irish
Takeover Rules, and permitted by applicable Law and regulation, the
Acquisition will not be made available directly or indirectly, in, into or
from any Restricted Jurisdiction and no person may vote in favour of the
Acquisition by any use, means, instrumentality or facilities from within a
Restricted Jurisdiction or any other jurisdiction if to do so would constitute
a violation of the Laws of that jurisdiction.
The release, publication or distribution of this Announcement in or into
certain jurisdictions may be restricted by the laws of those jurisdictions.
Accordingly, copies of this Announcement and all other documents relating to
the Acquisition are not being, and must not be, released, published, mailed or
otherwise forwarded, distributed or sent in, into or from any Restricted
Jurisdiction. Persons receiving such documents (including, without limitation,
nominees, trustees and custodians) should observe these restrictions. Failure
to do so may constitute a violation of the securities laws of any such
jurisdiction. To the fullest extent permitted by applicable law, Bidco,
Basware and Glantus disclaim any responsibility or liability for the
violations of any such restrictions by any person.
Overseas Shareholders
The distribution, release or publication of this announcement in or into
certain jurisdictions other than Ireland or the United Kingdom may be
restricted by the laws of those jurisdictions and therefore any persons who
are subject to the laws of any jurisdiction other than Ireland or the United
Kingdom should inform themselves about, and observe, any applicable
requirements. Any failure to comply with the applicable requirements may
constitute a violation of the securities laws of such jurisdiction. This
announcement is not intended to and does not constitute, or form part of, any
offer to sell or issue or an invitation to purchase or subscribe for any
securities or a solicitation of an offer to buy any securities pursuant to
this announcement or otherwise in any jurisdiction in which such offer or
solicitation is unlawful. This announcement has been prepared for the purposes
of complying with Irish law and the Irish Takeover Rules and the information
disclosed may not be the same as that which would have been disclosed if this
announcement had been prepared in accordance with the Laws and regulations of
any jurisdiction outside of Ireland.
The attention of Glantus Shareholders who are resident in, or citizens of, or
who have a contractual or legal obligation to forward this announcement to
persons in, Restricted Jurisdictions is drawn to paragraph 13 in Part III
(Explanatory Statement (In Compliance with Section 452 of the Act)) of the
Scheme Document.
APPENDIX
Expected Timetable of Principal Events
The following dates are provided by way of indicative guidance only, are subject to change and will depend, amongst other things, on the date on which certain Conditions to the Scheme are satisfied or, if capable of waiver, waived and on the date on which the Court sanctions the Scheme. Please also see note (1) below. Glantus will give adequate notice of all of these dates, when known, by issuing an announcement through a Regulatory Information Service. Further updates or changes to other times or dates
indicated below shall, at Glantus' discretion, be notified in the same way. Please also see note (2) below.
Event Time Date
Intended date to present petition to the High Court to issue directions to fix Court Hearing date 19 September 2023
Intended date for Court Hearing (of the petition to sanction the Scheme) 5 October 2023
Expected last day of dealings in Glantus Shares 5 October 2023
Scheme Record Time(4) 11:59 p.m. 5 October 2023
Effective Date of the Scheme 6 October 2023
Cancellation of the AIM listing of Glantus shares by the London Stock Exchange 9 October 2023
Settlement of cash consideration due under the Scheme within 14 days of the Effective Date
Notes:
(1) These dates are indicative only and will depend, among other
things, on the date upon which: (i) the conditions of the Scheme are satisfied
or (if capable of waiver) waived; and (ii) the sanction of the Scheme by the
High Court and the delivery of a copy of the Court Order to the Registrar of
Companies.
(2) All times shown in this document are GMT+1 unless otherwise
stated.
(3) Persons who hold their interests in Glantus Shares as
Belgian law rights through the Euroclear Bank System or as CDIs should consult
with their stockbroker or other intermediary at the earliest opportunity for
further information on the processes and timelines for submitting proxy votes
for the Scheme Meeting and EGM via their respective systems.
(4) Glantus Shares will be disabled in the EuroClear Bank System
from this time.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUOAOROOUKAAR